| Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)
  1.480
  
   
    +0.020 
    (+1.37%)
   
  
  
  Streaming Delayed Price
  Updated:  2:36 PM EDT, Oct 31, 2025
  Add to My Watchlist
  Headline News about Inhibikase Therapeutics, Inc. - Common Stock
    Inhibikase Posts Wider Loss in Q2
     August 14, 2025 Via The Motley Fool                         
    Dow Jumps Over 100 Points; Helen Of Troy Posts Upbeat Q2 Results
     October 09, 2024                         
   Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service. 
  © 2025 FinancialContent. All rights reserved.
  |  | 
| Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)
  1.480
  
   
    +0.020 
    (+1.37%)
   
  
  
  Streaming Delayed Price
  Updated:  2:36 PM EDT, Oct 31, 2025
  Add to My Watchlist
  Headline News about Inhibikase Therapeutics, Inc. - Common Stock
   Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service. 
  © 2025 FinancialContent. All rights reserved.
  |  |